Meridian Hospital Company PLC Deed of Variation to Concession Agreement (0980J)

TIDM39LU

RNS Number : 0980J

Meridian Hospital Company PLC

08 December 2022

Deed of VariationDeed of VarMeridian Hospital Company PLC (the "Issuer")

GBP91,200,000 4(3) /(16) PER CENT. SECURED INDEXED-LINKED BONDS DUE 2028 (the "Bonds")

(ISIN: XS0088950075)

RNS Announcement

Meridian Hospital Company Plc entered into a Deed of Variation to the Concession Agreement in relation to an NEC4 contract for Strategic Infrastructure Upgrades at the Queen Elizabeth Hospital, Greenwich on 29(th) November 2022 with the Lewisham and Greenwich NHS Trust, the cost of which will be fully met by the Lewisham and Greenwich NHS Trust.

The scope of works for the project includes the following major infrastructure replacements: Electrical Upgrades, Ventilation Upgrades and Medical Gas will be undertaken by Maclaren with support from Avanti Architects Limited, Clancy Consulting Limited and Vinci Construction Plc.

In accordance with Clause 15 'Negative Covenants - Amendments' of the Terms and Conditions of the Bond Trust Deed the Board of Directors confirm that the related documents do not have a Material Adverse Effect on the security granted in favour of the Security Trustee.

Company Secretary

Claire Jerome

For and on behalf of

Vercity Social Infrastructure (UK) Limited

8 White Oak Square

London Road

Swanley

BR8 7AG

Important information

This announcement is not a prospectus, is distributed for information purposes only and does not constitute or form part of any offer or invitation to issue, acquire or dispose of any securities in any jurisdiction. Nothing in this document is intended to amount to an invitation or inducement to engage in investment activity. Nothing in this document amounts to the giving of advice. If you are in any doubt as to the action you should take, you should consult a professional adviser.

M&G reserves all of the rights, powers, claims and remedies available to it under the Transaction Documents and applicable law. No delay or forbearance by M&G to exercise any right or remedy accruing under the terms of the Transaction Documents, other documentation relating thereto or under applicable law, shall impair any such right or remedy or constitute a waiver thereof or an acquiescence therein. Please note that this notice is not intended and should not be construed as investment, accounting, financial, legal, tax, or other advice by or on behalf of the Trustee, or its directors, officers, affiliates, attorneys, or employees. Each person or entity receiving this notice should seek the advice of its own advisors in respect of the matters set forth herein.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUWVARUVUURAA

(END) Dow Jones Newswires

December 08, 2022 06:58 ET (11:58 GMT)